North Carolina State University Researchers Identify Artemin As Breakthrough Biological Marker And Potential Therapeutic Target For Feline Osteoarthritis

NC State researchers find that artemin levels can diagnose feline osteoarthritis, offering a new target for chronic pain therapy and a simpler blood test.

By: AXL Media

Published: Mar 31, 2026, 10:23 AM EDT

Source: Information for this report was sourced from North Carolina State University

Mapping Feline Pain Pathways Through Molecular Comparison

Researchers at North Carolina State University have provided the most comprehensive evidence to date that feline degenerative joint disease closely parallels the biological features of human osteoarthritis. By analyzing the pain pathways active in cats, the team identified the specific role of artemin, a molecule that binds to the GFRA-3 receptor to activate pain-registering ion channels. This discovery confirms that the biological mechanisms underlying chronic joint pain are conserved across species, opening the door for cross-disciplinary medical advances that benefit both veterinary and human medicine.

The Role of TRP Ion Channels in Feline DJD

The study focused on transient receptor potential ion channels located within the spinal cord’s dorsal root ganglia, which function as cellular sensors for physical and chemical stimuli. In humans and dogs, these channels are known to express osteoarthritis pain once activated by artemin. Associate Professor Santosh Mishra noted that while these pathways were well-documented in other species, it was previously unknown if cats shared this specific biological framework. The research confirmed that these channels are not only present but fully functional in feline neurons, providing a clear target for future pharmacological intervention.

Diagnostic Potential of Blood Serum Analysis

One of the most significant practical applications of this research is the potential for a simplified diagnostic process for feline joint disease. Currently, veterinarians rely heavily on X-rays to confirm degenerative joint disease, a process that can be stressful and time-consuming for cats. The research team found that increased concentrations of artemin in blood serum correlated strongly with radiographic evidence of the disease. This suggests that a standard blood test could eventually replace or supplement imaging, allowing for earlier and less invasive detection of joint degradation in domestic cats.